- Home
- QURE vs VALN Comparison
QURE vs VALN Comparison
Compare QURE & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QURE
- VALN
- Stock Information
- Founded
- QURE 1998
- VALN 2012
- Country
- QURE Netherlands
- VALN France
- Employees
- QURE N/A
- VALN N/A
- Industry
- QURE Biotechnology: Pharmaceutical Preparations
- VALN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- QURE Health Care
- VALN Health Care
- Exchange
- QURE Nasdaq
- VALN Nasdaq
- Market Cap
- QURE 866.3M
- VALN 777.9M
- IPO Year
- QURE 2007
- VALN 2021
- Fundamental
- Price
- QURE $14.16
- VALN $9.97
- Analyst Decision
- QURE Strong Buy
- VALN Strong Buy
- Analyst Count
- QURE 11
- VALN 4
- Target Price
- QURE $39.91
- VALN $15.75
- AVG Volume (30 Days)
- QURE 1.1M
- VALN 120.7K
- Earning Date
- QURE 11-04-2025
- VALN 11-06-2025
- Dividend Yield
- QURE N/A
- VALN N/A
- EPS Growth
- QURE N/A
- VALN N/A
- EPS
- QURE N/A
- VALN N/A
- Revenue
- QURE $14,337,000.00
- VALN $230,566,060.00
- Revenue This Year
- QURE N/A
- VALN $14.76
- Revenue Next Year
- QURE $288.08
- VALN $24.11
- P/E Ratio
- QURE N/A
- VALN N/A
- Revenue Growth
- QURE N/A
- VALN 25.47
- 52 Week Low
- QURE $4.45
- VALN $3.62
- 52 Week High
- QURE $19.18
- VALN $12.25
- Technical
- Relative Strength Index (RSI)
- QURE 34.28
- VALN 59.97
- Support Level
- QURE $17.03
- VALN $8.72
- Resistance Level
- QURE $17.76
- VALN $9.19
- Average True Range (ATR)
- QURE 0.95
- VALN 0.35
- MACD
- QURE -0.39
- VALN -0.03
- Stochastic Oscillator
- QURE 3.13
- VALN 96.14
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.
About VALN Valneva SE
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.